PNRR, “Health Extended ALliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine – HEAL ITALIA.” SPOKE1 HOLISTIC NOSOLOGY. From patients to molecules & back: mapping the omic landscape of clinical to molecular environment to identify, classify, and refine the phenotypes of multifactorial disease. WP2 Transcriptomics: refinement of “common-soil” hypothesis & investigation on chronic pathological conditions for personalized stratification for therapeutics Task 2.2 Multi-omics approach for big killers: stratification of treatment response and tailored interventions. Codice progetto PE00000019″” dal 01/11/2022 al 31/10/2025; PI Prof. R. Marasa (€ 62.780,00);
RTDa su fondi PNRR: Dr. Atene Claudio Giacinto.
Ricerca Finalizzata Giovani Ricercatori 2021, “Exploring the role of Notch2 in mediating drug resistance in Chronic Lymphocytic Leukemia” GR-2021-12372864, dal 28/04/2023 al 28/04/2027; PI Dott.ssa Stefania Fiorcari, Host Laboratory Prof. R. Marasca. (€ 318.000,00).
Investigator Grant AIRC, Indoleamine-2,3-dioxygenase as a mediator of immune tolerance in chronic lymphocytic leukemia, dal 2018 al 2023, PI Prof. R. Marasca (€ 535.950,00).